FREEDOM EVO 100 EVO-2 100 10641100

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2013-08-14 for FREEDOM EVO 100 EVO-2 100 10641100 manufactured by Tecan Schweiz Ag.

Event Text Entries

[3592352] The laboratory called to report carryover between samples resulting in (b)(6) samples. The evo 100 instrument is used to transfer samples from the tube to a 96 well plate. All other processing is performed offline. After a (b)(6) sample, subsequent samples pipetted with the same tip also come out (b)(6). The lab noted formation of bubbles on the ends of tips 2, 3, and 6 after aspiration, although they indicated they had not observed bubbles dropping off of tips. Carryover is observed across the microtiter plate, not just limited to tips 2, 3, and 6. Problem was reported as ongoing since installation of instrument in january 2012, although this was the first report to tecan. The laboratory performs (b)(6) for insurance company and does not report results to physicians. Results are reported to insurance companies and their clients. The laboratory reported that all (b)(6) samples are confirmed by a second method and confirmatory test by western blot. The laboratory could not rule out if any (b)(6) results had been obtained. The laboratory indicated they do not plan to investigate past test results.
Patient Sequence No: 1, Text Type: D, B5


[11011044] A tecan field service engineer was dispatched to the laboratory to review the status of the instrument. The evoware log files were collected for review of the customer defined program for processing samples. The result of the review includes: the use of tween as part of the system fluid contributed to bubble formation - consider switching to di water without additives, include a decontamination step after each sample transfer, include an additional wash step at the beginning of the program, perform daily, weekly, monthly maintenance according to operator's manual and switch to using disposable tips from fixed tips. A gravimetric test was run on the instrument to verify dispense volumes. The gravimetric test did not meet manufacturer's specifications at the 10ul volume on tip. The dispense volume was around 15ul (too high). Fixed tip 6 was replaced and gravimetric tests rerun. All results met specification. The diagnostic test for fastwash and liquid detection test passed. It is likely that the use of fixed tips instead of disposable tips and insufficient use of decontamination and wash steps contributed to carryover. It is unclear if any false negative results occurred or if the failure in gravimetric test contributed to the carryover or potential for false negative results. Results are not used for treatment of patients and all positive samples are confirmed prior to reporting.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3003402518-2013-00005
MDR Report Key3303679
Report Source05
Date Received2013-08-14
Date of Report2013-08-13
Date of Event2013-07-19
Date Mfgr Received2013-07-19
Date Added to Maude2013-11-12
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactDR. ALEXANDER KRIEG
Manufacturer Street103 SEESTRASSE
Manufacturer CityMAENNEDORF, ZURICH 8708
Manufacturer CountrySZ
Manufacturer Postal8708
Manufacturer Phone449228560
Single Use3
Remedial ActionRP
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameFREEDOM EVO 100
Generic NamePIPETTING STATION FOR CLINICAL USE
Product CodeJQW
Date Received2013-08-14
Model NumberEVO-2 100
Catalog Number10641100
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerTECAN SCHWEIZ AG
Manufacturer AddressMAENNEDORF, ZURICH SZ


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2013-08-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.